Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-002241
Filing Date
2025-06-24
Accepted
2025-06-24 16:30:32
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3583
  Complete submission text file 0000905148-25-002241.txt   4986
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XENCOR INC. 465 N. HALSTEAD ST #200 PASADENA CA 91007
Business Address
Feigal Ellen (Reporting) CIK: 0001758108 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38905 | Film No.: 251069613